The effects of intrathecal magnesium and fentanyl added to bupivacaine on postoperative analgesic requirement in Patients undergoing lower limb orthopedic surgery
Phase 1
Completed
- Conditions
- post-operative pain inPatients undergoing lower limb orthopedic surgerypost-operative pain inPatients undergoing lower limb orthopedic surgeryAnaesthesiology - AnaestheticsSurgery - Surgical techniques
- Registration Number
- ACTRN12610000757011
- Lead Sponsor
- Qazvin Medical Science University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
patients with American Society of Anesthesiologists(ASA) physical status I and
II, undergoing elective femur surgery
Exclusion Criteria
significant coexisting disease such as hepato-renal and cardiovascular disease, any contraindication to regional anesthesia such as local infection or bleeding disorders, allergy to opioids, long-term opioid use or a history of chronic pain.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to first requirement of analgesic supplement(analgesic administration was initiated by patient request(verbal rating scale[ VRS]>4)[time to first requirement of analgesic supplement from the time of injection intrathecal anesthetic solution];postoperative analgesic requirements will be assessed by verbal rating scale (VRS) from 0 to 10 (0no pain, 10maximum imaginable pain)[12 hours postoperative (Each administration was initiated by patient request( VRS>4)]
- Secondary Outcome Measures
Name Time Method